As the market leader in point of care diagnostics in liver disease, Echosens™ continues to innovate the FibroScan® product line, bringing new solutions to meet your evolving needs for managing patients with liver disease.



FibroScan® Product Line

The dual-function capabilities of VCTE and CAP can support you across a many of the etiologies that comprise liver disease. FibroScan® is a true non-invasive point of care device, designed to give you the access, control and test consistency that you need for managing the growing numbers of patients. With Smart Tool technologies built into the examination and Echosens operator training and support, FibroScan® systems are designed to provide consistent and reliable measurements without the need for a certified sonographer.

The Echosens proprietary VCTE and CAP technologies are now available in both the FibroScan® 502 Touch stationary system and the new FibroScan® 530 Compact portable system. Both the stationary and portable FibroScan® systems offer the same VCTE and CAP testing functions, data acquisition procedures and report output options. Now your patients can benefit from FibroScan® testing without the constraints of device location.

Examinations with the FibroScan® systems are reimbursed under Category I CPT code 91200.

Innovation in Liver Disease Management
Using patented Vibration Controlled Transient Elastography (VCTE), the FibroScan® 502 Touch is the first noninvasive device indicated for use as an aid in the clinical management of patients with liver disease.

Learn More →

Enhancing access through mobility
The FibroScan® 530 Compact offers the same dual function capabilities and examination experience as the FibroScan® 502 Touch.

Learn More →